METASTATIC BREAST CANCER
Clinical trials for METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial aims to unlock best drug sequence for tough breast cancer
Disease control Not yet recruitingThis study is for people with a specific type of advanced breast cancer that has spread. It will test which of two newer, targeted drugs to try first, and which to try second if the first one stops working. The goal is to find the best order to give these treatments to help contr…
Matched conditions: METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for tough breast cancers: trial tests promising drug combo
Disease control Not yet recruitingThis study is testing whether a new drug called RC48, when combined with standard chemotherapy, works better than current standard treatments for advanced HER2-positive breast cancer. It's for people whose cancer has continued to grow despite previous treatment with a specific ty…
Matched conditions: METASTATIC BREAST CANCER
Phase: PHASE2, PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New device trial offers hope for advanced breast cancer patients out of options
Disease control Not yet recruitingThis study is testing a device called TheraBionic P1 to see if it can help control advanced breast cancer and help patients live longer. It is for women whose cancer has spread and has stopped responding to standard hormone therapies and chemotherapy. The device is held in the mo…
Matched conditions: METASTATIC BREAST CANCER
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Cancer Drug's Real-World performance under the microscope
Disease control Not yet recruitingThis study aims to monitor the safety and effectiveness of the breast cancer drug TUKYSA in real-world medical practice in Korea. It will enroll 600 adults with advanced HER2-positive breast cancer who are starting TUKYSA treatment as prescribed by their doctor. The main goal is …
Matched conditions: METASTATIC BREAST CANCER
Sponsor: Pfizer • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug combo tested for Tough-to-Treat breast cancer
Disease control Not yet recruitingThis study is testing a new two-drug combination (JSKN016 given by IV and D-0502 taken as a pill) for people with advanced breast cancer that is hormone-sensitive and HER2-negative, and that has worsened after standard hormone-based therapy. The main goals are to find a safe dose…
Matched conditions: METASTATIC BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Smart trial aims to match breast cancer drugs to Patients' unique tumors
Disease control Not yet recruitingThis study aims to find better treatments for advanced breast cancer by matching therapies to specific tumor characteristics. It will enroll 700 patients whose cancer has progressed after initial treatment. Doctors will analyze tumor markers and assign standard treatments accordi…
Matched conditions: METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
New hope for Tough-to-Treat breast cancer: testing a powerful drug duo
Disease control Not yet recruitingThis study is testing whether combining two drugs, elacestrant and trastuzumab deruxtecan, can help control advanced breast cancer that has grown despite prior hormone-based therapies. It will involve about 65 people with specific types of breast cancer (HR+/HER2-low or ultralow)…
Matched conditions: METASTATIC BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sarah Sammons, MD • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
New scan could spot failing cancer drugs months earlier
Diagnosis Not yet recruitingThis study aims to determine if PET scans can identify ineffective cancer treatment earlier than standard CT scans. Researchers will compare PET scans against CT scans in 262 patients with metastatic breast cancer receiving T-DXd therapy. The goal is to help patients avoid contin…
Matched conditions: METASTATIC BREAST CANCER
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Diagnosis
Last updated Mar 17, 2026 12:55 UTC
-
Virtual support groups aim to boost wellness for women with advanced breast cancer
Symptom relief Not yet recruitingThis study is testing a virtual lifestyle program to see if it can help women with stable, advanced breast cancer improve their diet, exercise, and stress management. It will compare three different levels of support to find the best way to help participants stick with the progra…
Matched conditions: METASTATIC BREAST CANCER
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 09, 2026 14:25 UTC